BARRY THOMAS GERARD has a total of 12 patent applications. Its first patent ever was published in 1989. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology and pharmaceuticals are PRIMAGEN HOLDING BV, BIOMIRNA HOLDINGS LTD and RESPONSE GENETICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | Ireland | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Barry Thomas Gerard | 12 |
#2 | Maher Majella | 8 |
#3 | Tuite Nina | 5 |
#4 | Lahiff Sinead | 5 |
#5 | O'Connor Louise | 5 |
#6 | Smith Terence James | 5 |
#7 | Jankiewicz Marcin | 4 |
#8 | Smith Terry James | 4 |
#9 | O'Grady Justin | 2 |
#10 | Powell Richard | 2 |
Publication | Filing date | Title |
---|---|---|
US2011218335A1 | eIF2γ gene as a diagnostic target for the identification of fungal and yeast species | |
US2011217704A1 | LepA/Guf1 gene sequences as a diagnostic target for the identification of bacterial species | |
IE891287L | Generation of specific probes for target nucleotide sequences |